SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation
Public ClinicalTrials.gov record NCT01053962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, 14-Day Repeat, Oral, Dose Ranging Study to Assess the Safety, Pharmacokinetic and Pharmacodynamic Effects of SP-304 in Patients With Chronic Idiopathic Constipation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a, randomized, double-blind, placebo-controlled, 14-day repeat oral, dose ranging study to determine the safety, pharmacokinetics (PK) and pharmacodynamics (PD) effects of SP-304 in patients with chronic idiopathic constipation.
Study identification
- NCT ID
- NCT01053962
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 84 participants
Conditions and interventions
Conditions
Interventions
- SP-304 0.3 mg Drug
- SP-304 1.0 mg Drug
- SP-304 3.0 mg Drug
- SP-304 9.0 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2010 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Aug 2010 (Actual)
- Last update posted
- Jan 2, 2020
2010
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novara Clinical Research | Mesa | Arizona | 85206 | — |
| Genova Clinical Research | Tucson | Arizona | 85741 | — |
| Advanced Clinical Research | Anaheim | California | 92801 | — |
| Advanced Clinical Research | Orange | California | 92869 | — |
| A.G.A. Clinical Trials | Hialeah | Florida | 33012 | — |
| Miami Ressearch and Associates | Miami | Florida | 33143 | — |
| Lee Research Institute | Shawnee Mission | Kansas | 66218 | — |
| Clinical Research Institute of Michigan, LLC | Chesterfield | Michigan | 48047 | — |
| Universtiy of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Memphis Gastroenterology Group | Germantown | Tennessee | 38138 | — |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | — |
| DCOL Center for Clinical Research | Longview | Texas | 75605 | — |
| Pioneer Research Solutions | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01053962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 2, 2020 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01053962 live on ClinicalTrials.gov.